Dengue – Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets Harvard Case Solution & Analysis

This case explores the difficulties entailed in commercialising vaccines in low income settings. The focus is the dengue vaccine, established at the end of 2015, which was first commercialised in emergent markets.

It considers issues of affordability and distribution, higlighting the need for business model innovation in all industries.

PUBLICATION DATE: January 25, 2016 PRODUCT #: IN1139-PDF-ENG

This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP

Share This